← Leaderboards
Ester J. Kwon
University Of Washington
$2,541,824
Attributed
$2,541,824
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.4M · FY2009–18$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$2,541,824 · 3
By mechanism
DP2$2,362,500 · 1
F32$138,479 · 1
F31$40,845 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Washington
Same institution · by research overlap
- Craig Lewis Duvall$15,130,944
- Mark D Johnson$9,663,116
- Suzie H Pun$10,440,289
- Miqin Zhang$12,482,841
- Kim A. Woodrow$13,186,657
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoUptakeAnimal ModelIn VitroPeptidesTraffickingLabelMediatingLuciferasesParticleCellsBaseBinding (Molecular Function)TechnologyPropertyNeurodegenerative DisordersAffectNeuronsInnovationAreaMalignant NeoplasmsDrug FormulationsNovel TherapeuticsApoptosis
Grant awards (6)
Nanoscale Biomaterials for Targeted Repair in Traumatic Brain Injury$2,362,500
DP2 · FY2018 · NS · contact PI
Peptide-mediated delivery of siRNA for treatment of ovarian cancer$26,575
F32 · FY2016 · CA · contact PI
Peptide-mediated delivery of siRNA for treatment of ovarian cancer$57,962
F32 · FY2015 · CA · contact PI
Peptide-mediated delivery of siRNA for treatment of ovarian cancer$53,942
F32 · FY2013 · CA · contact PI
Dvelopment of multi-component peptide vehicles for in vivo neuronal gene therapy$9,693
F31 · FY2010 · NS · contact PI
Dvelopment of multi-component peptide vehicles for in vivo neuronal gene therapy$31,152
F31 · FY2009 · NS · contact PI